Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.8.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
HK.8.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
HK.8.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.8.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.19.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
XBB.1.19.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
XBB.1.19.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.19.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.19.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GE.1.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
GE.1.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
GE.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GE.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GE.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.6.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
EG.6.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
EG.6.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.6.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FU.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
FU.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
FU.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FU.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FU.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.7.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
DV.7.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
DV.7.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.86.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
BA.2.86.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
BA.2.86.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.86.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.86.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.3.12ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
HK.3.12ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
HK.3.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.3.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GN.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
GN.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
GN.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JG.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
JG.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
JG.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used